Increased cerebrospinal fluid levels of substance P in patients with amyotrophic lateral sclerosis. Short communication.
To clarify the mechanism of brain and spinal cord impairment in amyotrophic lateral sclerosis (ALS), we measured the cerebrospinal fluid (CSF) levels of substance P (SP) in 11 patients with sporadic ALS. Findings were compared with those obtained in controls and diseased controls. The CSF SP levels of patients with ALS, and particularly in patients with a disease duration of less than 2.5 years, were significantly higher than those in controls. These findings strongly suggested that SP may play an important role in the pathophysiology of ALS.
Matsuishi
T
T
Department of Pediatrics and Child Health, Kurume University School of Medicine, Fukuoka, Japan.
Nagamitsu
S
S
Shoji
H
H
Itoh
M
M
Takashima
S
S
Iwaki
T
T
Shida
N
N
Yamashita
Y
Y
Sakai
T
T
Kato
H
H
D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000134:cerebrospinal fluid*; D015415:Biomarkers / Q000134:cerebrospinal fluid; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000134:cerebrospinal fluid; D010523:Peripheral Nervous System Diseases / Q000134:cerebrospinal fluid; D013373:Substance P / Q000134:cerebrospinal fluid*
D015415:Biomarkers; D013373:Substance P